Combined COVID-flu vaccines are coming: Moderna jab clears major test
https://www.nature.com/articles/d41586-024-02121-1
NEWS
28 June 2024
Combined COVID-flu vaccines are coming: Moderna jab clears major test
First large trial suggests mRNA drug gives better protection from SARS-CoV-2 and influenza viruses than single-target shots.
By Freda Kreier
A single vaccine has been shown to protect people from both SARS-CoV-2 and influenza viruses and with a higher effectiveness than vaccines that target one or the other, the pharmaceutical company Moderna has announced.
Moderna, which is based in Cambridge, Massachusetts, said earlier this month that it had successfully completed phase-III clinical trials for the drug, which like the companys pioneering COVID-19 vaccines is based on mRNA. In a statement to its investors, Moderna said that the vaccine was more effective at providing immunity to adults over the age of 50 than competing flu and COVID-19 shots.
Moderna is now planning to seek approval from the US Food and Drug Administration (FDA) to bring the vaccine to market.
Combination vaccines can have big public-health benefits, but they are often time-consuming and expensive to develop. Modernas latest rapid success shows that RNA can help to overcome some of these difficulties, says James Thaventhiran, a clinical immunologist at the University of Cambridge, UK, This is a great example of why the technology is exciting, he says, adding that the combination vaccines using mRNA are just the beginning for RNA technology.
[...]